179 related articles for article (PubMed ID: 30508603)
1. In vitro analysis of synthetic peptides in blocking the entry of dengue virus.
John AM; Jittmittraphap A; Chattanadee S; Alwin Prem Anand A; Shenbagarathai R; Leaungwutiwong P
Virus Res; 2019 Jan; 260():142-150. PubMed ID: 30508603
[TBL] [Abstract][Full Text] [Related]
2. A Synthetic Bioactive Peptide Derived from the Asian Medicinal Plant
Panya A; Sawasdee N; Songprakhon P; Tragoolpua Y; Rotarayanont S; Choowongkomon K; Yenchitsomanus PT
Viruses; 2020 Nov; 12(11):. PubMed ID: 33172110
[TBL] [Abstract][Full Text] [Related]
3. A peptide inhibitor derived from the conserved ectodomain region of DENV membrane (M) protein with activity against dengue virus infection.
Panya A; Sawasdee N; Junking M; Srisawat C; Choowongkomon K; Yenchitsomanus PT
Chem Biol Drug Des; 2015 Nov; 86(5):1093-104. PubMed ID: 25891143
[TBL] [Abstract][Full Text] [Related]
4. Peptide inhibitors against dengue virus infection.
Panya A; Bangphoomi K; Choowongkomon K; Yenchitsomanus PT
Chem Biol Drug Des; 2014 Aug; 84(2):148-57. PubMed ID: 24612829
[TBL] [Abstract][Full Text] [Related]
5. Geraniin extracted from the rind of Nephelium lappaceum binds to dengue virus type-2 envelope protein and inhibits early stage of virus replication.
Abdul Ahmad SA; Palanisamy UD; Tejo BA; Chew MF; Tham HW; Syed Hassan S
Virol J; 2017 Nov; 14(1):229. PubMed ID: 29162124
[TBL] [Abstract][Full Text] [Related]
6. Antiviral activity of silymarin and baicalein against dengue virus.
Low ZX; OuYong BM; Hassandarvish P; Poh CL; Ramanathan B
Sci Rep; 2021 Oct; 11(1):21221. PubMed ID: 34707245
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of dengue virus entry into target cells using synthetic antiviral peptides.
Alhoot MA; Rathinam AK; Wang SM; Manikam R; Sekaran SD
Int J Med Sci; 2013; 10(6):719-29. PubMed ID: 23630436
[TBL] [Abstract][Full Text] [Related]
8. The antimicrobial peptide HS-1 inhibits dengue virus infection.
Monteiro JMC; Oliveira MD; Dias RS; Nacif-Marçal L; Feio RN; Ferreira SO; Oliveira LL; Silva CC; Paula SO
Virology; 2018 Jan; 514():79-87. PubMed ID: 29153860
[TBL] [Abstract][Full Text] [Related]
9. Anti-dengue virus serotype 2 activity and mode of action of a novel peptide.
Chew MF; Tham HW; Rajik M; Sharifah SH
J Appl Microbiol; 2015 Oct; 119(4):1170-80. PubMed ID: 26248692
[TBL] [Abstract][Full Text] [Related]
10. In vitro inhibition of dengue virus entry by p-sulfoxy-cinnamic acid and structurally related combinatorial chemistries.
Rees CR; Costin JM; Fink RC; McMichael M; Fontaine KA; Isern S; Michael SF
Antiviral Res; 2008 Nov; 80(2):135-42. PubMed ID: 18606464
[TBL] [Abstract][Full Text] [Related]
11. Development of novel antiviral peptides against dengue serotypes 1-4.
Lee MF; Anasir MI; Poh CL
Virology; 2023 Mar; 580():10-27. PubMed ID: 36739680
[TBL] [Abstract][Full Text] [Related]
12. Novel, anionic, antiviral septapeptides from mosquito cells also protect monkey cells against dengue virus.
Laosutthipong C; Kanthong N; Flegel TW
Antiviral Res; 2013 Jun; 98(3):449-56. PubMed ID: 23603496
[TBL] [Abstract][Full Text] [Related]
13. Changes in antiviral susceptibility to entry inhibitors and endocytic uptake of dengue-2 virus serially passaged in Vero or C6/36 cells.
Acosta EG; Piccini LE; Talarico LB; Castilla V; Damonte EB
Virus Res; 2014 May; 184():39-43. PubMed ID: 24583230
[TBL] [Abstract][Full Text] [Related]
14. Peptide inhibitors of dengue virus and West Nile virus infectivity.
Hrobowski YM; Garry RF; Michael SF
Virol J; 2005 Jun; 2():49. PubMed ID: 15927084
[TBL] [Abstract][Full Text] [Related]
15. In silico screening of small molecule libraries using the dengue virus envelope E protein has identified compounds with antiviral activity against multiple flaviviruses.
Kampmann T; Yennamalli R; Campbell P; Stoermer MJ; Fairlie DP; Kobe B; Young PR
Antiviral Res; 2009 Dec; 84(3):234-41. PubMed ID: 19781577
[TBL] [Abstract][Full Text] [Related]
16. Drug repurposing of quinine as antiviral against dengue virus infection.
Malakar S; Sreelatha L; Dechtawewat T; Noisakran S; Yenchitsomanus PT; Chu JJH; Limjindaporn T
Virus Res; 2018 Aug; 255():171-178. PubMed ID: 30055216
[TBL] [Abstract][Full Text] [Related]
17. Identification of the phytobioactive Polygonum cuspidatum as an antiviral source for restricting dengue virus entry.
Kuo YT; Liu CH; Li JW; Lin CJ; Jassey A; Wu HN; Perng GC; Yen MH; Lin LT
Sci Rep; 2020 Oct; 10(1):16378. PubMed ID: 33009425
[TBL] [Abstract][Full Text] [Related]
18. Narasin, a novel antiviral compound that blocks dengue virus protein expression.
Low JS; Wu KX; Chen KC; Ng MM; Chu JJ
Antivir Ther; 2011; 16(8):1203-18. PubMed ID: 22155902
[TBL] [Abstract][Full Text] [Related]
19. Antiviral activity of chondroitin sulphate E targeting dengue virus envelope protein.
Kato D; Era S; Watanabe I; Arihara M; Sugiura N; Kimata K; Suzuki Y; Morita K; Hidari KI; Suzuki T
Antiviral Res; 2010 Nov; 88(2):236-43. PubMed ID: 20851716
[TBL] [Abstract][Full Text] [Related]
20. A novel flavanone derivative inhibits dengue virus fusion and infectivity.
Srivarangkul P; Yuttithamnon W; Suroengrit A; Pankaew S; Hengphasatporn K; Rungrotmongkol T; Phuwapraisirisan P; Ruxrungtham K; Boonyasuppayakorn S
Antiviral Res; 2018 Mar; 151():27-38. PubMed ID: 29360474
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]